Patents by Inventor John S. Eid

John S. Eid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions relating to microbial treatment and diagnosis of disorders
    Patent number: 11931387
    Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
    Type: Grant
    Filed: July 22, 2020
    Date of Patent: March 19, 2024
    Assignee: Pendulum Therapeutics, Inc.
    Inventors: Colleen Cutcliffe, John S. Eid, James H. Bullard, Marcus F. Schicklberger
  • Methods and Compositions for Treatment of Microbiome Associated Disorders
    Publication number: 20230372411
    Abstract: Disclosed herein are methods and compositions for treatment of a microbiome associated disorder. Further, disclosed herein are methods and compositions for modulating short chain fatty acid production in a subject.
    Type: Application
    Filed: January 23, 2023
    Publication date: November 23, 2023
    Inventors: Colleen CUTCLIFFE, John S. EID, Tomer ALTMAN, Orville G. KOLTERMAN, James H. BULLARD
  • Methods and compositions for treatment of microbiome-associated disorders
    Patent number: 11583558
    Abstract: Disclosed herein are methods and compositions for treatment of a microbiome associated disorder. Further, disclosed herein are methods and compositions for modulating short chain fatty acid production in a subject.
    Type: Grant
    Filed: February 28, 2020
    Date of Patent: February 21, 2023
    Assignee: PENDULUM THERAPEUTICS, INC.
    Inventors: Colleen Cutcliffe, John S. Eid, Tomer Altman, Orville G. Kolterman, James H. Bullard
  • Compositions Comprising Microbes and Methods of Use and Making Thereof
    Publication number: 20230050043
    Abstract: The disclosure provides microbial compositions (e.g., compositions comprising one or more microbes or protein components thereof), that can be administered to subjects to confer beneficial effects. Disclosed compositions can, for example, be useful in reducing visceral hypersensitivity, or pain in response to colorectal distension.
    Type: Application
    Filed: December 22, 2020
    Publication date: February 16, 2023
    Inventors: Jeewon Garcia-So, Nicholas B. Justice, Magdalena K. Stoeva, John S. Eid, Julia N. Myers, Andrew T. Cheng, Moe Brandi, Paul McMurdie, James H. Bullard
  • Methods and Compositions Comprising a Bacteria with Increased Viability and Faster Revivability
    Publication number: 20220395541
    Abstract: Methods to increase viability and revivability of bacteria compared to their wild type counterparts, are disclosed herein. New strains of an anerobic bacteria is also disclosed obtained by the methods described herein. Further, disclosed are compositions comprising these bacteria as well as methods of treatment including the use of the bacteria described.
    Type: Application
    Filed: December 18, 2020
    Publication date: December 15, 2022
    Inventors: Nicholas B. Justice, Magdalena K. Stoeva, John S. Eid
  • Methods and compositions relating to microbial treatment and diagnosis of disorders
    Patent number: 11364270
    Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
    Type: Grant
    Filed: August 25, 2021
    Date of Patent: June 21, 2022
    Assignee: Pendulum Therapeutics, Inc.
    Inventors: Colleen Cutcliffe, John S. Eid, James H. Bullard, Marcus F. Schicklberger
  • Methods and compositions relating to microbial treatment and diagnosis of disorders
    Patent number: 11278580
    Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: March 22, 2022
    Assignee: Pendulum Therapeutics, Inc.
    Inventors: Colleen Cutcliffe, John S. Eid, James H. Bullard, Marcus F. Schicklberger
  • Methods and compositions relating to microbial treatment and diagnosis of disorders
    Patent number: 11213556
    Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: January 4, 2022
    Assignee: Pendulum Therapeutics, Inc.
    Inventors: Colleen Cutcliffe, John S. Eid, James H. Bullard, Marcus F. Schicklberger
  • METHODS AND COMPOSITIONS RELATING TO MICROBIAL TREATMENT AND DIAGNOSIS OF DISORDERS
    Publication number: 20210386798
    Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
    Type: Application
    Filed: August 25, 2021
    Publication date: December 16, 2021
    Inventors: Colleen CUTCLIFFE, John S. EID, James H. BULLARD, Marcus F. SCHICKLBERGER
  • MICROBIAL COMPOSITIONS AND METHODS OF USE
    Publication number: 20210213078
    Abstract: Administering a composition comprising at least one mucin-regulating and at least one butyrate-producing microbe can provide a therapeutic effect for subjects having prediabetes or type 2 diabetes. Therapeutic effects can include a reduction in hemoglobin A1C levels, a reduction in glucose area under the curve after a meal tolerance test, or a reduction in the fasting glucose level.
    Type: Application
    Filed: March 23, 2021
    Publication date: July 15, 2021
    Inventors: John S. EID, Colleen CUTCLIFFE, Orville KOLTERMAN, Fanny PERRAUDEAU, James BULLARD, Paul MCMURDIE, Andrew CHENG, Marcus SCHICKLBERGER, Nicholas JUSTICE
  • METHODS AND COMPOSITIONS FOR MICROBIAL ENGRAFTMENT
    Publication number: 20210205374
    Abstract: The disclosure provides compositions and methods for therapeutic administration of the compositions to treat comorbidities associated with gut dysbiosis. The disclosure also provides compositions and methods for increasing engraftment of administered microbes. The disclosure also provides methods for stool sample collection.
    Type: Application
    Filed: January 15, 2021
    Publication date: July 8, 2021
    Inventors: John S. EID, Colleen CUTCLIFFE, James H. BULLARD, Nicholas JUSTICE, Jessica GINES, Surabhi TYAGI, Marcus F. SCHICKLBERGER, Andrew T. CHENG, Paul MCMURDIE, Christian SIEBER
  • Methods and compositions relating to microbial treatment and diagnosis of disorders
    Patent number: 10842831
    Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: November 24, 2020
    Assignee: Pendulum Therapeutics, Inc.
    Inventors: Colleen Cutcliffe, John S. Eid, James H. Bullard, Marcus F. Schicklberger
  • Methods and compositions relating to microbial treatment and diagnosis of disorders
    Patent number: 10842830
    Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: November 24, 2020
    Assignee: Pendulum Therapeutics, Inc.
    Inventors: Colleen Cutcliffe, John S. Eid, James H. Bullard, Marcus F. Schicklberger
  • METHODS AND COMPOSITIONS RELATING TO MICROBIAL TREATMENT AND DIAGNOSIS OF DISORDERS
    Publication number: 20200345796
    Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
    Type: Application
    Filed: July 22, 2020
    Publication date: November 5, 2020
    Inventors: Colleen CUTCLIFFE, John S. EID, James H. BULLARD, Marcus F. SCHICKLBERGER
  • METHODS AND SYSTEMS FOR MICROBIOME CHARACTERIZATION, MONITORING AND TREATMENT
    Publication number: 20200277658
    Abstract: The present disclosure provides methods for profiling a microbiome and therapeutic compositions for treatment. Additionally, the methods, systems, compositions and kits provided herein are directed to assessing or predicting health status in a subject. Some of the embodiments include generating a report.
    Type: Application
    Filed: March 12, 2020
    Publication date: September 3, 2020
    Inventors: Colleen CUTCLIFFE, John S. EID, James H. BULLARD
  • METHODS AND COMPOSITIONS FOR TREATMENT OF MICROBIOME-ASSOCIATED DISORDERS
    Publication number: 20200268811
    Abstract: Disclosed herein are methods and compositions for treatment of a microbiome associated disorder. Further, disclosed herein are methods and compositions for modulating short chain fatty acid production in a subject.
    Type: Application
    Filed: February 28, 2020
    Publication date: August 27, 2020
    Inventors: Colleen CUTCLIFFE, John S. EID, Tomer ALTMAN, Orville G. KOLTERMAN, James H. BULLARD
  • METHODS AND COMPOSITIONS RELATING TO MICROBIAL TREATMENT AND DIAGNOSIS OF DISORDERS
    Publication number: 20200261518
    Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
    Type: Application
    Filed: March 26, 2020
    Publication date: August 20, 2020
    Inventors: Colleen CUTCLIFFE, John S. EID, James H. BULLARD, Marcus F. SCHICKLBERGER
  • METHODS AND COMPOSITIONS RELATING TO MICROBIAL TREATMENT AND DIAGNOSIS OF DISORDERS
    Publication number: 20200261517
    Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
    Type: Application
    Filed: March 26, 2020
    Publication date: August 20, 2020
    Inventors: Colleen CUTCLIFFE, John S. EID, James H. BULLARD, Marcus F. SCHICKLBERGER
  • Methods and compositions relating to microbial treatment and diagnosis of disorders
    Patent number: 10675312
    Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: June 9, 2020
    Assignee: Pendulum Therapeutics, Inc.
    Inventors: Colleen Cutcliffe, John S. Eid, James H. Bullard, Marcus F. Schicklberger
  • Methods and compositions relating to microbial treatment and diagnosis of disorders
    Patent number: 10668116
    Abstract: The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. The present disclosure provides for treatment of metabolic conditions using microbial compositions.
    Type: Grant
    Filed: September 21, 2016
    Date of Patent: June 2, 2020
    Assignee: Pendulum Therapeutics, Inc.
    Inventors: Colleen Cutcliffe, John S. Eid, James H. Bullard, Marcus F. Schicklberger